Investors
ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.
ImmunoPrecise Antibodies Ltd. Stock Information
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News & Releases page.
Investor Relations
For investor inquiries please contact: LifeSci Advisors John Mullaly jmullaly@lifesciadvisors.comFinancial Statements
Please find our financials on Sedar in English and Français.Analyst Coverage
Download Industrielle Alliance Report Chelsea Stellick +1 (403) 705 4982 chelsea.stellick@iagto.caImmunoPrecise Newsletter
Check out our most recent blog post:Understanding the Chain of InfectionEarnings Call
The Company held an earnings conference call via webcast on September 9th, 2021. View a recording of the earnings call or view a transcript of the earnings callSign Up for
Email Alerts
Enter your email to receive financial information by email.
Eligible French companies involved with us in research and development may receive a tax credit. Learn More.